# Nuclide record florastamin-f18 (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/florastamin-f18/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "florastamin-f18" ;
  schema:name "Florastamin F-18"@en ;
  schema:alternateName "18F-florastamin"@en, "ProstaView"@en, "Prostaview Injection"@en, "florastamine"@en, "flortastamine F-18"@en, "ProstaView" ;
  schema:description "Florastamin is FutureChem's fluorine-18 PSMA PET tracer, and the first prostate cancer diagnostic developed in South Korea to be approved there — Korea's 43rd domestically developed new drug."@en ;
  schema:url <https://nuclide.cc/drugs/florastamin-f18/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://en.sedaily.com/finance/2026/05/04/futurechem-wins-approval-for-koreas-first-prostate-cancer>, <https://en.edaily.co.kr/news/eda202608205175/>, <https://doi.org/10.1097/RLU.0000000000005798>, <https://doi.org/10.1016/j.prnil.2025.07.001>, <https://clinicaltrials.gov/search?intr=FC303> ;
  nuclide:status "approved" ;
  nuclide:tag "diagnostic", "psma", "korea", "ctgov-ingest" ;
  nuclide:modality "PSMA-targeted PET radiotracer, fluorine-18" ;
  nuclide:approval "South Korea 2026: PET imaging of PSMA-positive lesions in men with prostate cancer whose existing imaging suggests recurrence or metastasis" ;
  nuclide:related <https://nuclide.cc/institutions/ksnm/>, <https://nuclide.cc/journals/nuclear-medicine-and-molecular-imaging/>, <https://nuclide.cc/isotopes/f-18/>, <https://nuclide.cc/indications/prostate-bcr/>, <https://nuclide.cc/isotopes/ga-68/>, <https://nuclide.cc/isotopes/lu-177/> ;
  nuclide:indications <https://nuclide.cc/indications/prostate/> ;
  nuclide:technologies <https://nuclide.cc/technologies/psma-pet/>, <https://nuclide.cc/technologies/pet/> ;
  nuclide:targets <https://nuclide.cc/targets/psma/> ;
  nuclide:companies <https://nuclide.cc/companies/futurechem/> ;
  nuclide:trials <https://nuclide.cc/trials/nct05936658/>, <https://nuclide.cc/trials/nct05004285/>, <https://nuclide.cc/trials/nct06754085/> .